Lipids in gestational diabetes: Abnormalities and significance

Gestational Diabetes During and After Pregnancy

Volumn , Issue , 2010, Pages 155-169

  Knopp, Robert H ^a   Chan, Elizabeth ^a   Zhu, Xiaodong ^a   Paramsothy, Pathmaja ^a   Bonet, Bartolome ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890007144     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-120-0_11     Document Type: Chapter

References (55)

1. Knopp R, Bonet B, Zhu X-D. Lipid metabolism in pregnancy. In: Cowett R, ed. Principles of Perinatal-Neonatal Metabolism. New York: Springer; 1998: 221-258.
2. Knopp RH, Bergelin RO, Wahl P.W., Walden CE, Chapman M, Irvine S. Population-based lipoprotein lipid reference values for pregnant women compared to nonpregnant women clas-sified by sex hormone usage. Am J Obstet Gynecol. 1982; 143: 626-637.
3. Knopp R, Paramsothy P. Part Management of diabetic/medical complications in pregnancy: management of hyper/dyslipidmias. In: Kitzmiller J, Jovanovic L, Brown F, Coustan D, Reader D, eds. Managing Preexisting Diabetes and Pregnancy: Technical Reviews and Consensus Recommendations for Care. Alexandria: American Diabetes Association; 2008: 355-374.
4. Alvarez JJ, Montelongo A, Iglesias A., Lasuncion MA, Herrera E. Longitudinal study on lipo-protein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res. 1996; 37: 299-308.
5. Magnusson-Olsson A.L., Hamark B, Ericsson A., Wennergren M, Jansson T, Powell TL Gestational and hormonal regulation of human placental lipoprotein lipase. J Lipid Res. 2006; 47: 2551-2561.
6. Larque E, Krauss-Etschmann S, Campoy C., et al Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr. 2006; 84: 853-861.
7. van Eijsden M., Hornstra G, van der Wal MF, Vrijkotte TG, Bonsel GJ. Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. Am J Clin Nutr. 2008; 87: 887-895.
8. Banka CL. High density lipoprotein and lipoprotein oxidation. Curr Opin Lipidol. 1996; 7: 139-142.
9. Vaisar T, Pennathur S, Green P.S., et al Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest. 2007; 117: 746-756.
10. Grunfeld C, Feingold KR HDL and innate immunity: a tale of two apolipoproteins. J Lipid Res. 2008; 49: 1605-1606.
11. Oram JF. The ins and outs of ABCA. J Lipid Res. 2008; 49: 1150-1151.
12. Lasuncion MA, Bonet B, Knopp RH Mechanism of the HDL2 stimulation of progesterone secretion in cultured placental trophoblast. J Lipid Res. 1991; 32: 1073-1087.
13. Woollett LA. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr. 2005; 82: 1155-1161.
14. Schmid KE, Davidson WS, Myatt L, Woollett LA Transport of cholesterol across a BeWo cell monolayer: implications for net transport of sterol from maternal to fetal circulation. J Lipid Res. 2003; 44: 1909-1918.
15. Stefulj J, Panzenboeck U, Becker T., et al Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res. 2009; 104: 600-608.
16. Madsen EM, Lindegaard ML, Andersen C.B., Damm P., Nielsen LB Human placenta secretes apolipoprotein B-100-containing lipoproteins. J Biol Chem. 2004; 279: 55271-55276.
17. Portman OW, Behrman RE, Soltys P. Transfer of free fatty acids across the primate placenta. Am J Physiol. 1969; 216: 143-147.
18. Campbell FM, Clohessy AM, Gordon M.J., Page KR, Dutta-Roy AK. Uptake of long chain fatty acids by human placental choriocarcinoma (BeWo) cells: role of plasma membrane fatty acid-binding protein. J Lipid Res. 1997; 38: 2558-2568.
19. Koletzko B, Larque E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J Perinat Med. 2007; 35(SUPPL. 1): S5-S11.
20. Knopp RH, Bergelin RO, Wahl P.W., Walden CE Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes. 1985; 34(SUPPL. 2):71-77.
21. Weng W, Breslow JL Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci U S A. 1996; 93: 14788-14794.
22. Kalopissis AD, Pastier D, Chambaz J. Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance. Curr Opin Lipidol. 2003; 14: 165-172.
23. Knopp RH, Magee MS, Walden C.E., Bonet B., Benedetti TJ Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care. 1992; 15: 1605-1613.
24. Arbogast BW, Lee GM, Raymond TL In vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serum. Diabetes. 1982; 31: 593-599.
25. Hubel CA, McLaughlin MK, Evans R.W., Hauth BA, Sims CJ, Roberts JM Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol. 1996; 174: 975-982.
26. Pou KM, Massaro JM, Hoffmann U, et al Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007; 116: 1234-1241.
27. Knopp RH. Drug treatment of lipid disorders. N Engl J Med. 1999; 341: 498-511.
28. Napoli C, D'Armiento FP, Mancini FP, et al Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997; 100: 2680-2690.
29. Napoli C, Glass CK, Witztum J.L., Deutsch R., D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999; 354: 1234-1241.
30. Montes A, Walden CE, Knopp R.H., Cheung M., Chapman MB, Albers JJ Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpar-tum. Possible markers for the diagnosis of "prelipemia". Arteriosclerosis. 1984; 4: 407-417.
31. Sanchez-Vera I., Bonet B, Viana M., et al Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metabolism. 2007; 56: 1527-1533.
32. Hollingsworth DR, Grundy SM Pregnancy-associated hypertriglyceridemia in normal and diabetic women. Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes. 1982; 31: 1092-1097.
33. Di Cianni G., Miccoli R, Volpe L., et al Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med. 2005; 22: 21-25.
34. Warth MR, Knopp RH Lipid metabolism in pregnancy. V. Interactions of diabetes, body weight, age and high carbohydrate diet. Diabetes. 1977; 26: 1056-1062.
35. Knopp RH, Chapman M, Bergelin R., Wahl PW, Warth MR, Irvine S. Relationships of lipopro-tein lipids to mild fasting hyperglycemia and diabetes in pregnancy. Diabetes Care. 1980; 3: 416-420.
36. Couch SC, Philipson EH, Bendel R.B., Wijendran V., Lammi-Keefe CJ. Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus. Predictors of birth weight? J Reprod Med. 1998; 43: 816-822.
37. Knopp RH, Warth MR, Carrol CJ Lipid metabolism in pregnancy. I. Changes in lipoprotein triglyceride and cholesterol in normal pregnancy and the effects of diabetes mellitus. J Reprod Med. 1973; 10: 95-101.
38. Qiu C, Rudra C, Austin M.A., Williams MA Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size. Physiol Res. 2007; 56: 571-578.
39. Scifres C, Chen B, Nelson D., Sadovsky Y. The influence of maternal obesity and diabetes on placental lipi trafficking. J Obster Gynec. 2008; 199: S22. abstract #50.
40. Lindegaard ML, Damm P, Mathiesen E.R., Nielsen LB Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res. 2006; 47: 2581-2588.
41. Ortega-Senovilla H., Alvino G, Taricco E., Cetin I, Herrera E. Gestational diabetes mellitus upsets the proportion of fatty acids in umbilical arterial but not venous plasma. Diabetes Care. 2009; 32: 120-122.
42. Kitajima M, Oka S, Yasuhi I., Fukuda M, Rii Y, Ishimaru T. Maternal serum triglyceride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol. 2001; 97: 776-780.
43. Schaefer-Graf U.M., Graf K, Kulbacka I., et al Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care. 2008; 31: 1858-1863.
44. Bomba-Opon D., Wielgos M, Szymanska M., Bablok L. Effects of free fatty acids on the course of gestational diabetes mellitus. Neuro Endocrinol Lett. 2006; 27: 277-280.
45. Hansel B, Giral P, Nobecourt E., et al Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired anti-oxidative activity. J Clin Endocrinol Metab. 2004; 89: 4963-4971.
46. Tesauro M, Schinzari F, Rovella V., et al Tumor necrosis factor-alpha antagonism improves vaso-dilation during hyperinsulinemia in metabolic syndrome. Diabetes Care. 2008; 31: 1439-1441.
47. Kim C, Cheng YJ, Beckles GL Inflammation among women with a history of gestational diabetes mellitus and diagnosed diabetes in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2008; 31: 1386-1388.
48. Chen X, Scholl TO Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr Diab Rep. 2005; 5: 282-288.
49. Coughlan MT, Permezel M, Georgiou H.M., Rice GE Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes. J Clin Endocrinol Metab. 2004; 89: 3585-3594.
50. Bonet B, Hauge-Gillenwater H, Zhu X.D., Knopp RH LDL oxidation and human placental trophoblast and macrophage cytotoxicity. Proc Soc Exp Biol Med. 1998; 217: 203-211.
51. Wentzel P, Gareskog M, Eriksson UJ Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats. Diabetes. 2008; 57: 3344-3352.
52. Hubel CA, Roberts JM, Taylor R.N., Musci TJ, Rogers GM, McLaughlin MK Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol. 1989; 161: 1025-1034.
53. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. Bjog. 2001; 108: 1081-1087.
54. Branch DW, Mitchell MD, Miller E, Palinski W., Witztum JL Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet. 1994; 343: 645-646.
55. Liguori A, D'Armiento FP, Palagiano A, et al Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids. Bjog. 2007; 114: 1547-1556.